Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
Keyword(s):
2016 ◽
Vol 7
(5)
◽
pp. 711-717
◽
Keyword(s):
2017 ◽
Vol 9
(3)
◽
pp. 567-572
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 17
(10)
◽
pp. 994-1002
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 120
◽
pp. S51
◽
Keyword(s):